Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 35Gastrointestinal 27Thoracic 25Other hematologic neoplasm 24Genitourinary 21Other solid neoplasm 17Head & Neck 16Gynecologic 13Tumor-Agnostic 10Lymphoid 9Dermatologic 6CNS 6Plasma cell 5Sarcoma 3Myeloid 3Other 2Other neoplasm 1Endocrine 1Classical hematology 1

Conditions

Obesity, Abdominal 1Chemotherapy-Induced Peripheral Neuropathy 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Practice Guidelines as Topic × Other × Clear all
NCT06945380 2026-05-06

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Mayo Clinic

Phase NA Recruiting
300 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

NCT03120390 2020-12-17

Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors

University of Southern California

Phase NA Withdrawn
Other

Obesity, Abdominal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡